Esperion Therapeutics, Inc. (ESPR) scores 57 out of 100 on boothcheck's 11-model valuation framework. Verdict: Hold The estimated fair value is $3.11, representing a 13% margin of safety. Quantitative score: 73/100. Qualitative score: 20/100.
Analysis includes bear, base, and bull fair value targets using DCF, Graham, regression, and 8 other valuation models.